scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1162131G |
P356 | DOI | 10.1371/JOURNAL.PONE.0162131 |
P932 | PMC publication ID | 5006968 |
P698 | PubMed publication ID | 27579698 |
P50 | author | Sarah J. Glastras | Q51694443 |
Hui Chen | Q41044744 | ||
Rachel T McGrath | Q43228926 | ||
P2093 | author name string | Jason Chen | |
Muh Geot Wong | |||
Carol A Pollock | |||
Sonia Saad | |||
Rachel Teh | |||
P2860 | cites work | Obesity-Related Chronic Kidney Disease-The Role of Lipid Metabolism | Q26774143 |
Lessons from mouse models of high-fat diet-induced NAFLD | Q26829532 | ||
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas | Q28217509 | ||
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway | Q28509217 | ||
A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-β1 | Q28543256 | ||
Prevalence of chronic kidney disease in the United States | Q29614191 | ||
Obesity-related glomerulopathy: an emerging epidemic | Q34190647 | ||
The use of animal models in diabetes research | Q34255921 | ||
Chronic kidney disease: global dimension and perspectives | Q34347984 | ||
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective | Q34503601 | ||
Diabetes mellitus: The epidemic of the century | Q34671155 | ||
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity | Q34979668 | ||
Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress | Q35126070 | ||
Dysplastic hepatocytes develop nuclear inclusions in a mouse model of viral hepatitis | Q35188743 | ||
C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. | Q51570758 | ||
Nongenetic mouse models of non-insulin-dependent diabetes mellitus. | Q54134954 | ||
Receiver operating characteristic analysis of glycogenated nuclei in liver biopsy specimens: quantitative evaluation of their relationship with diabetes and obesity | Q72719983 | ||
Influence of long-term diabetes on renal glycogen metabolism in the rat | Q73431013 | ||
Beraprost sodium, a stable prostacyclin analogue, improves insulin resistance in high-fat diet-induced obese mice | Q83769966 | ||
Challenges of chronic kidney disease prevention | Q87241606 | ||
Protein aggregation in recombinant bacteria: biological role of inclusion bodies. | Q35545575 | ||
Development of a nongenetic mouse model of type 2 diabetes | Q35580004 | ||
Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort | Q35666503 | ||
Obesity, metabolic health, and the risk of end-stage renal disease | Q35667706 | ||
Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease | Q35739217 | ||
Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics | Q35781864 | ||
FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity. | Q36294501 | ||
Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity | Q36719266 | ||
Animal models of obesity | Q36742593 | ||
Histopathology of diabetic nephropathy | Q36785588 | ||
Rodent models of streptozotocin-induced diabetic nephropathy | Q36820026 | ||
High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice. | Q36937909 | ||
Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. | Q36956072 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
The modern spectrum of renal biopsy findings in patients with diabetes | Q37212364 | ||
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy | Q37603244 | ||
Obesity Related Kidney Disease | Q37808494 | ||
Direct and indirect effects of obesity on the kidney | Q38084514 | ||
Obesity-related glomerulopathy and the nephron complement | Q38122630 | ||
Diabetic kidney disease: a report from an ADA Consensus Conference. | Q38254458 | ||
Experimental diabetes induced by alloxan and streptozotocin: The current state of the art. | Q38644013 | ||
Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury | Q42186397 | ||
Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions | Q42932026 | ||
Structural and functional changes in the kidneys of high-fat diet-induced obese mice | Q46275989 | ||
Evaluating the glucose tolerance test in mice | Q46350758 | ||
Glycogen accumulation in renal tubules, a key morphological change in the diabetic rat kidney | Q46535863 | ||
Mouse Models for Studying Diabetic Nephropathy | Q46715584 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
P304 | page(s) | e0162131 | |
P577 | publication date | 2016-08-31 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Mouse Models of Diabetes, Obesity and Related Kidney Disease | |
P478 | volume | 11 |
Q47797046 | Adenine-induced chronic kidney disease in rats |
Q91755491 | Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney Injury |
Q47548477 | Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice |
Q55456375 | Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus. |
Q52608853 | Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain. |
Q41034789 | Effect of synergistic interaction between abnormal adiposity-related metabolism and prediabetes on microalbuminuria in the general population |
Q41072417 | Effects of high-intensity interval versus mild-intensity endurance training on metabolic phenotype and corticosterone response in rats fed a high-fat or control diet |
Q41320071 | Green Tea Polyphenols Ameliorate the Early Renal Damage Induced by a High-Fat Diet via Ketogenesis/SIRT3 Pathway |
Q47179983 | Inactivation of SPAK kinase reduces body weight gain in mice fed a High-fat diet by improving energy expenditure and insulin sensitivity |
Q96680410 | Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents |
Q58699037 | Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia |
Q50421794 | Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring |
Q90395699 | Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice |
Q64318064 | Potential use of transgenic domestic pigs expressing recombinant human erythropoietin in diabetes translation research |
Q90564083 | Resveratrol Protects Against Renal Damage via Attenuation of Inflammation and Oxidative Stress in High-Fat-Diet-Induced Obese Mice |
Q64116871 | Synergistic Hypoglycemic Effects of Pumpkin Polysaccharides and Puerarin on Type II Diabetes Mellitus Mice |
Q96306423 | Temporal pressure enhanced topical drug delivery through micropore formation |
Q88215222 | The Influence of Obesity on the Pharmacokinetics of Dioxin in Mice: An Assessment Using Classical and PBPK Modeling |
Q50421864 | Timing of host feeding drives rhythms in parasite replication |
Q47693328 | Trigonelline Inhibits Inflammation and Protects β Cells to Prevent Fetal Growth Restriction during Pregnancy in a Mouse Model of Diabetes |
Search more.